Mongiovi Jennifer M, Townsend Mary K, Vitonis Allison F, Harris Holly R, Doherty Jennifer A, Babic Ana, Hecht Jonathan L, Soong T Rinda, Titus Linda, Conejo-Garcia Jose R, Fridley Brooke L, Tworoger Shelley S, Terry Kathryn L, Sasamoto Naoko
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Cancer Epidemiol Biomarkers Prev. 2025 Apr 3;34(4):550-559. doi: 10.1158/1055-9965.EPI-24-1414.
Parity and breastfeeding are associated with systemic changes in maternal inflammation and reduced risk of ovarian cancer, but little is known about their impact on the ovarian tumor immune microenvironment.
We evaluated the associations of self-reported parity and history of breastfeeding with tumor-infiltrating T cells among 1,706 ovarian carcinoma cases with tumor tissue collected across four studies. The abundance of tumor-infiltrating T cells was measured by multiplex immunofluorescence in tumor tissue microarrays. ORs and 95% confidence intervals (CI) for the positivity of tumor immune cells were calculated using beta-binomial models and stratified by histotype.
Compared with ovarian tumors in nulliparous women, there was no association between parity and ovarian tumor T-cell abundance among all histotypes combined but suggestion of increased cytotoxic T cells and T-cell exhaustion among parous women with clear-cell tumors. When restricted to parous women, history of breastfeeding was associated with increased odds for all T-cell types [i.e., total T, cytotoxic T, helper T (Th), regulatory T, and exhausted T cells], with ORs ranging from 1.11 to 1.42. For every 6 months of breastfeeding, we observed increased odds of activated Th-cell infiltration (CD3+CD4+CD69+; OR, 1.13, 95% CI, 0.99-1.29), with a similar association for high-grade serous tumors, but lower odds in clear-cell tumors (OR, 0.43, 95% CI, 0.21-0.87).
History of breastfeeding may alter the ovarian tumor immune microenvironment by modulating the abundance of tumor-infiltrating T cells.
Although replication is required, history of breastfeeding may play a role in the activation of the ovarian tumor immune response.
生育次数和母乳喂养与母体炎症的系统性变化以及卵巢癌风险降低相关,但它们对卵巢肿瘤免疫微环境的影响知之甚少。
我们在四项研究中收集了肿瘤组织的1706例卵巢癌病例中,评估了自我报告的生育次数和母乳喂养史与肿瘤浸润性T细胞之间的关联。通过肿瘤组织微阵列中的多重免疫荧光法测量肿瘤浸润性T细胞的丰度。使用β-二项式模型计算肿瘤免疫细胞阳性的比值比(OR)和95%置信区间(CI),并按组织学类型分层。
与未生育女性的卵巢肿瘤相比,所有组织学类型合并后,生育次数与卵巢肿瘤T细胞丰度之间无关联,但在患有透明细胞肿瘤的经产妇中,细胞毒性T细胞和T细胞耗竭有增加的迹象。当仅限于经产妇时,母乳喂养史与所有T细胞类型(即总T细胞、细胞毒性T细胞、辅助性T细胞、调节性T细胞和耗竭性T细胞)的增加几率相关,OR范围为1.11至1.42。每进行6个月的母乳喂养,我们观察到活化的辅助性T细胞浸润(CD3 + CD4 + CD69 +)的几率增加(OR,1.13,95% CI,0.99 - 1.29),高级别浆液性肿瘤有类似关联,但在透明细胞肿瘤中几率较低(OR,0.43,95% CI,0.21 - 0.87)。
母乳喂养史可能通过调节肿瘤浸润性T细胞的丰度来改变卵巢肿瘤免疫微环境。
尽管需要重复验证,但母乳喂养史可能在卵巢肿瘤免疫反应的激活中起作用。